SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-380589
Filing Date
2014-10-24
Accepted
2014-10-23 20:46:07
Documents
4
Period of Report
2014-10-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d808092d8k.htm 8-K 18826
2 EX-10.1 d808092dex101.htm EX-10.1 41523
3 EX-99.1 d808092dex991.htm EX-99.1 7413
4 GRAPHIC g808092image001.jpg GRAPHIC 4596
  Complete submission text file 0001193125-14-380589.txt   75809
Mailing Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949
Business Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949 415-408-6200
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25571 | Film No.: 141170984
SIC: 2834 Pharmaceutical Preparations